Keyphrases
COVID-19
100%
Lopinavir
100%
Platform Trials
100%
Usual Care
71%
Invasive Mechanical Ventilation
42%
No Significant Difference
28%
Standard of Care
28%
Treatment Group
28%
Rate Ratio
28%
Active Groups
28%
Web-based
14%
Randomized Trial
14%
Non-associated
14%
In Vitro Activity
14%
All-cause Mortality
14%
Active Treatment
14%
Intention-to-treat
14%
Risk of Death
14%
Improved Outcomes
14%
Risk Ratio
14%
Composite Endpoint
14%
Allocation Concealment
14%
Length of Hospital Stay
14%
Possible Treatments
14%
Azithromycin
14%
Hydroxychloroquine
14%
28-day Mortality
14%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
100%
Dexamethasone
100%
Observational Study
100%
Preclinical Study
100%
Hydroxychloroquine
100%
Azithromycin
100%
Nursing and Health Professions
Artificial Respiration
100%
Health Care Quality
66%
Rate Ratio
66%
Randomization
66%
Hospitalization
33%
Intention to Treat Analysis
33%
All Cause Mortality
33%
Azithromycin
33%
Preclinical Study
33%
Hydroxychloroquine
33%
Dexamethasone
33%
Medicine and Dentistry
COVID-19
100%
Artificial Respiration
50%
In Vitro
16%
Observational Study
16%
Intention-to-Treat Analysis
16%
Mouth
16%
All Cause Mortality
16%
Dexamethasone
16%
Azithromycin
16%
Hydroxychloroquine
16%